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A B S T R A C T
Objective: To characterize the participatory and democratic creation of the Brazilian 
guidelines for biorepositories and biobanks of human biological material with the purpose 
of research based on the ethical principles of human dignity, autonomy, beneficence, 
justice, and precaution. 
Methods: An interdisciplinary work group was constituted to prepare the document, 
considering the following criteria: experience in biobank operation, regional representation, 
type of stored biological material, and bioethics specialists. Members of the National Health 
Surveillance Agency (Agência Nacional de Vigilância Sanitária – Anvisa), also participated 
due to their regulatory competence. Members from the National Commission on Ethics 
in Research (Comissão Nacional de Ética em Pesquisa – Conep) participated as the social 
control organization.
Results: The document, based on ethical, legal, and technical guidelines, presents the 
concepts, activities, purposes, and differences between biorepositories and biobanks; forms 
of consent on the part of the subject; in addition to other aspects permeated by concerns 
regarding the appropriate use of information. The Brazilian guidelines for biorepository and 
biobank of human biological material with the purpose of research contains 39 articles, 
which are distributed in five chapters. 
Conclusion: The importance of legislation arises from the ethical concern, considering 
morals and taking into account the legal aspects, which translate into a document that 
does not end in itself. The dynamics of science always leads to changes in paradigms, 
which can go beyond the existing laws.
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
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Introduction
The biorepositories and biobanks of human biological 
material – body fluids, cells, tissues, intracellular 
substances, and DNA – and associated information, have 
become an important resource for biomedical research, and 
the development of diagnostic and therapeutic procedures.1 
For a long time, the storage of human biological material 
was carried out by researchers in research institutes and 
hospitals, mainly in the departments of pathology, being 
mostly performed in a disorderly manner and without 
associating information of related clinical data. 
A worldwide concern has been the establishment of a 
coordinated network of biobanks that respect the ethical, 
legal, and technical guidelines of the member countries. In 
international discussions, the need and the importance of 
feasible cooperation between local institutions and between 
institutions from different countries has been observed, as 
well as the need for the organization of recommendations 
regarding language patterns, forms of communication, 
bioinformatics system, and specific terminology for the 
designation of human biological materials. 
Regarding the ethical aspects, informed consent calls into 
question whether reconsent is needed for each research, or 
just the initial consent; recontact and information provision 
to the individual; feedback of research results to trial 
participants; and who is in charge of their interpretation 
and distribution, in addition to matters of privacy and 
confidentiality of data through information system security 
policies.2,3 Regarding the technical aspects, working 
organization is crucial, as well as the phases of collection, 
processing, storage, distribution and disposal of human 
biological material, and financial aspects involved in both 
the initial development – facilities and infrastructure – and 
subsequent maintenance.4 Concerning the legal issues, the 
intellectual property (patents, copyrights) of the biological 
material and sharing policies of information and stored 
materials, at both national and international level, must 
be considered. 
This organization process is interdisciplinary, relying 
on the participation of many individuals from the 
natural sciences and humanities fields, such as health 
professionals, philosophers, sociologists, bioethicists, 
systems analysts, managers, among others, who must 
have great responsibility regarding the confidentiality of 
the biological material5 and the protection of the individual. 
To date, Brazil does not have an ordinary law regarding 
research involving humans, nor a specific law concerning 
the storage and use of human biological material in research. 
However, there is a legislative basis in the Constitution of 
19885 -in Article 199, which provides for the disposition 
of conditions and requirements for the elimination of 
human samples for research purposes, among others, 
highlighting the aspect of the prohibition of any kind of 
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R E S U M O
Objetivo: Caracterizar a construção participativa e democrática das Diretrizes Nacionais 
para Biorrepositório e Biobanco de Material Biológico Humano com Finalidade de Pesquisa, 
baseada nos princípios éticos da dignidade humana, da autonomia, da beneficência, da 
justiça e da precaução. 
Métodos: Para a elaboração do documento formou-se um grupo de trabalho interdisciplinar 
considerando os seguintes critérios: experiência na operacionalização de biobancos, 
representatividade regional, tipo de material biológico acondicionado e especialistas em 
bioética. Participaram, também, membros da Agência Nacional de Vigilância Sanitária 
– Anvisa, pela competência regulatória e da Comissão Nacional de Ética em Pesquisa – 
Conep, enquanto controle social. 
Resultados: O documento, baseado nos preceitos éticos, legais e técnicos, apresenta os 
conceitos, as atividades, finalidades e diferenças entre biorrepositórios e biobancos, as 
formas de consentimento do sujeito, além de outros aspectos permeados pela preocupação 
do uso adequado da informação. As Diretrizes Nacionais para Biorrepositório e Biobanco 
de Material Biológico Humano com Finalidade de Pesquisa contém 39 artigos, dispostos em 
cinco capítulos. 
Conclusão: A importância de uma regulamentação surge da reflexão ética, considerando a 
moral, e tendo como norteador os aspectos legais, os quais se traduzem em um documento 
que não se esgota em si mesmo. A dinamicidade da ciência sempre nos remete à mudança 
de paradigmas, que podem ir além das legislações existentes.
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
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commercialization. The Civil Code and other legislation 
on related matters also provide a legislative basis, such as 
the Law 11.105/05 (Biosafety Act), which establishes safety 
standards and control mechanisms for activities involving 
genetically modified organisms and their derivatives, and 
the use of embryonic stem cells; the RDC6 23/11 – Agência 
Nacional de Vigilância Sanitária (Anvisa), which regulates 
with technical standards for the operation of cell and 
germinative tissue banks;7 and the Resolution CNS 347/05, 
which regulated the use of human biological material in 
the context of research projects,8 which can be considered 
a regulatory and historic milestone for research in this field 
of knowledge. 
The nonexistence of the law weakens the control of the 
National Health Council and of the Federal Government 
on research activities involving human subjects when 
performed by removing human biological material. In 
this sense, the new Brazilian normative documents, CNS 
Resolution 441 of 2011,9 which revokes the CNS Resolution 
347 of 2005, and the Decree of the Brazilian Ministry of 
Health presented here, are of great importance for the 
regulation of this issue, especially when considering 
the implementation and operation of the new Brazilian 
biobanks for research purposes.
The present article aims to characterize the participatory 
and democratic creation of the Decree of the Brazilian 
Ministry of Health that establishes the Brazilian guidelines 
for biorepositories and biobanks of human biological 
material with research purpose,10 based on the ethical 
principles of human dignity, autonomy, beneficence, 
justice, and precaution. 
History of the creation of the Brazilian Guidelines 
Considering the international scenario on the organization 
of biobanks, which intensified during the end of 2008, 
and considering the appeal from the national scientific 
community, the Brazilian Ministry of Health decided to 
organize and, in January 2009, the Department of Science 
and Technology, through the Coordination of Research 
Ethics and Bioethics, began assessing the theme and 
prioritized as one of its actions, the need for national 
guidelines to regulate the storage and use of human 
biological material in research, especially considering the 
need to establish and operate appropriate biobanks in the 
country.  
The identification of Brazilian institutions that had 
biobanks was crucial for the development of this study. 
During this mapping, it was observed that most institutions 
only had biorepositories. The National Institute of Cancer 
(Instituto Nacional do Câncer – INCA) and the Hospital AC 
Camargo maintained properly established biobanks. 
When preparing the document, an interdisciplinary 
work group was constituted considering the following 
criteria: experience in biobank operation, regional 
representation, type of stored biological material, and 
bioethics specialists. Members of the National Health 
Surveillance Agency – Anvisa, due to their regulatory 
competence, also participated, as well as members from 
the National Commission on Ethics in Research (Comissão 
Nacional de Ética em Pesquisa – Conep), as the social control 
organization. 
Concomitantly, the Brazilian Ministry of Health and 
the Conep were represented in national and international 
discussion forums that addressed the issue of biobanks. 
Participation in these meetings showed that Brazil was 
in the same state-of-the-art as other countries, and 
consolidated aspects that should be addressed in this 
document. 
The first meeting of the working group resulted in 
an initial proposal that was discussed and improved in 
subsequent meetings, in addition to contributions from 
the National Health Council (Conselho Nacional de Saúde – 
CNS) and Conep. This proposal was reviewed internally at 
Decit with the participation of legal counsel of the Brazilian 
Ministry of Health, resulting in the text that was published 
in the Official Gazette (Diário Oficial da União – DOU) on 
April 12, 2010, and presented for public consultation in May, 
2010. This consultation resulted in 229 contributions that 
were compiled and analyzed during the final draft of the 
document.5 
It should be noted that all technical policy guidelines 
issued by the Brazilian Ministry of Health are extensively 
discussed with the three branches of government and 
civil society representatives, such as managers, service 
providers, researchers, health professionals, and user 
representatives, thus resulting in an agreement that was 
democratic and egalitarian.
The creation of the National Guidelines 
When developing the guidelines, national and international 
provisions were considered, such as laws, declarations, 
regulations, resolutions, and scientific production related 
to the theme. Recognizing the different competencies 
of research institutions in Brazil, and that many health 
institutions have repositories of human biological material, 
the document refers to biorepositories and biobanks.
Thus, the guidelines aim to establish the principles and 
standards to be used when establishing and operating 
biobanks and biorepositories of human biological material 
for research purposes, as well as the information related 
to the samples that comprise them, and to ensure ethical 
and legal standards of the procedures regarding their use. 
These guidelines are governed by the bioethical principles 
of human dignity, autonomy, beneficence, justice, and 
precaution. The bioethical principles were crucial for the 
creation of the guidelines, as it is known that they promote 
not only the building of standards but also awareness of 
ethical values  , and that they can influence, directly or 
indirectly, the formulation of health policies.11
The document discusses the conceptual aspects, 
activities, goals, and differences between biorepositories 
and biobanks; consent forms; the rights of the research 
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subjects; and other aspects permeated by concerns on the 
appropriate use of information. The Decree of the Ministry 
of Health number 2201 from September 14, 2011, which 
established the Brazilian guidelines for biorepositories 
and biobanks of human biological material with research 
purpose, was published in the DOU on September 15, 2011; 
it contains 39 articles, which are divided in five chapters 
and arranged as follows: 
Chapter I: On general dispositions
Chapter II: On consent
Chapter III: On the research subject’s rights 
Chapter IV: On biorepositories and biobanks
Section I – On general dispositions
Section II - On biorepositories
Section III - On biobanks
Chapter V: On final dispositions
The first chapter is preceded by considerations that 
include the Constitution of the Federative Republic of 
Brazil, the mainstay of the principle of human dignity and 
fundamental rights to life, liberty, and physical and moral 
integrity; the Civil Code; the principles of the Brazilian 
Unified Health System (Sistema Único de Saúde – SUS), 
particularly the preservation of the autonomy of individuals 
in defense of their physical and moral integrity, equality 
of health care without prejudices or privileges of any kind, 
and the right of the assisted persons to have information 
about their health; the provisions stated in international 
documents such as the Nuremberg Code, the Universal 
Declaration of Human Rights, the Declaration of Helsinki, 
the International Ethical Guidelines for Biomedical Research 
Involving Human Subjects (CIOMS/WHO), the Universal 
Declaration on Bioethics and Human Rights, the Universal 
Declaration on the Human Genome and Human Rights, 
and the International Declaration on Human Genetic Data 
and Recommendations of the World Health Organization 
on Common Minimum Technical Standards and Protocols 
for Biological Resource Centers (WHO/IARC); the Brazilian 
laws, particularly Law No. 9.279/96, which regulates the 
rights and obligations related to industrial property, and 
Law #11.105/05 which concerns biosafety; the National 
Health Council Resolutions pertaining to the subject; 
Resolution #358/05 of the National Environment Council; 
and Resolution #306/04 of Anvisa’s Collegiate Board that 
are relevant to the topic.  
In accordance with Chapter I of the Decree, article 3,a 
biobank is an organized collection of human biological 
material and associated information collected and stored 
for research purposes, in accordance with pre-defined 
ethical and operational regulations or technical standards; 
the stored material is under institutional responsibility and 
management, with non-profit objectives.
In biobanks, the human biological material belongs to the 
research subject, and its safekeeping and management is 
the responsibility of the institution, with indefinite storage 
time, i.e., as long as the material is viable, requiring quality 
control to ensure the reliability of the material to be used 
in biological research.
To establish a biobank, it is necessary to submit 
a development protocol that will be analyzed by the 
institutional research ethics committee (REC) or one 
indicated by Conep and, when approved, it will be 
compulsorily evaluated by Conep. 
The development protocol is the document that defines 
the creation and operation of a biobank, its managers, and 
its fundamental aspects, such as the informed consent to 
be used; the information related to the subject and to the 
samples; and the steps of collection, processing, storing, 
distributing, and disposing of human biological material. 
It must be accompanied by the Internal Regulations for 
Biobanks, which includes the characteristics, purpose, 
organizational structure and modus operandi of each biobank, 
and by the institutional disclaimer, which is a statement of 
technical and financial responsibility for the creation and 
maintenance of the biobank, as provided in the Brazilian 
Ministry of Health Decree.  
Regarding the biorepository, it is a collection of 
human biological material, collected and stored during 
the performance of a specific research project, according 
to regulations or pre-defined technical, ethical, and 
operational standards, under institutional responsibility 
and researcher management, for non-commercial use.  
Human biological material stored in a biorepository 
is also the property of the research subject, whereas 
the institution and its researchers are in charge of its 
management; the storage period should be in accordance 
with the chronogram of the corresponding research, and 
should meet the current standards of the CNS.
The biorepositories and biobanks should adopt a set of 
practices, equipment and facilities aimed at preventing, 
minimizing, or eliminating risks inherent to research 
activities, with goals of human health, preservation of the 
environment, and quality of results. 
According to Chapter II of the Decree, the subject’s 
consent to the collection, storage, and use of human 
biological material in a biobank is necessarily formalized 
through the informed consent (IC). This document should 
contain two options, mutually exclusive, regarding the 
use of stored material for every study, for purposes of the 
expressed and individual decision on the part of the subject: 
the need for a new consent, or new consent waiver. 
Thus, the individuals’ right to choose to give their 
consent regarding future use of their biological material 
stored in biobanks is explained and ensured, in projects 
approved by the national system of ethical assessment 
of research in human subjects at the same time that the 
individuals give their authorization for collection and 
storage, exempting new contacts for obtaining and clarifying 
the consent. Conversely, the subject’s right to be informed 
about the purpose of the use of the samples stored at each 
approved research remains, if it is his/her will, and he/she 
76 REV ASSOC MED BRAS. 2013; 59(1):72-77
can decide whether or not to give consent, after contact 
and presentation of his/hers IC. In this situation, if the 
subject refuses to give consent to the use of the material, 
the sample cannot be used against his/her will, preserving 
the individual’s interests and decision. In the particular 
case in which the subject cannot be found, even if he/she 
opted for new contact and consent for each research, upon 
presentation of reasonable justifications by the researcher, 
the REC may or may not authorize the use of the stored 
sample. 
Regarding the IC for the use of human biological samples 
in a biorepository, it must be specific for each research, as 
recommended by the resolutions of the CNS.
In Chapter III of this document, the rights of the 
research subjects have to be detailed and must appear 
in the IC, such as: free access to information associated 
with the stored human biological material; free access 
to information obtained or generated from the human 
biological material used; free access to genetic information 
obtained or generated from the human biological 
material used, including those that imply risks for non-
preventable diseases or familial risks; free access to genetic 
counseling, if applicable; anonymity in any form of release 
of the information or results associated with the human 
biological material used; withdrawal of consent at any time; 
designation of persons who may have access to their genetic 
information in the event of death or disabling condition; 
and access to information on storage purposes, including 
those responsible for it, the risks and potential benefits, 
guarantee of quality and integrity of storage, as well as 
measures to ensure privacy and confidentiality.  
Regarding the feedback of research results to participants 
expressed in Article 4, paragraph 3 of the Decree, and 
the right to free access to genetic counseling in Chapter 
III, Article 8, section IV, it must be emphasized that the 
Brazilian position on this issue is to ensure, through a 
normative document, that the participant has the right 
to decide whether or not to be informed about research 
results, depending on the manifestation of his will, and to 
receive genetic counseling, when the results of research 
show known and consistent clinical implications during the 
course of a research project.
Throughout Chapter IV, on biorepositories and biobanks, 
in addition to the general provisions relating to both, the 
differences between them are described; for instance, 
regarding the management, time of storage, and disposal 
of human biological material. In Section III of this Chapter, 
it is noted that biobanks should be accredited in the REC/
Conep system, and will be subject to inspection by the 
health authorities. 
According to Chapter V of the said Decree, biobanks 
established  from the date of its publication onward should 
be created in accordance with it, and those previously 
established should comply within one year. Compliance 
with the standards contained in this decree shall be subject 
to review and approval by REC/Conep system. Moreover, 
CNS resolutions on human biological material shall be 
considered. 
Final considerations
The guidelines issued in this article do not exhaust the 
complexity of the different aspects involved in the use of 
biological materials stored in biobanks and biorepositories. 
The importance of regulations arises from ethical precepts, 
considering the morality prevailing in the country, and 
taking into account the legal aspects, which translate into 
a document that does not end in itself. The dynamics of 
science always leads to changes in paradigms, which can 
go beyond the existing laws. 
It is expected that the Brazilian Ministry of Health Decree 
that established the Brazilian guidelines for biorepositories 
and biobanks of human biological material with the purpose 
of research will enable the strengthening of ethical and 
legal standards in studies based on information from 
biorepositories and biobanks, contributing to the existing 
quality standards in Brazilian scientific publications. 
Considering the international context, and specifically that 
of Latin America, it is noteworthy that Brazil was one of the 
pioneers in developing a document of this magnitude, with 
the purpose of research. 
The importance of researchers’ and institutions’ 
adherence to this document when performing projects that 
are consistent with the existing standards is emphasized, 
guaranteeing the continuity of the academic excellence that 
Brazil has attained in the international scenario. 
In parallel, Conep found it was necessary to review and 
update the CNS Resolution 347/05. Thus, in May 2011, this 
document was revoked and replaced by CNS Resolution 
441/11. Therefore, nationally, there are two complementary 
documents that govern the subject – the National Health 
Council Resolution and the Decree of the Ministry of Health.
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